Treating Medication-Resistant Panic Disorder: Predictors and Outcome of Cognitive-Behavior Therapy in a Brazilian Public Hospital
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: In Brazil, treatment of panic disorder is most frequently initiated with pharmacotherapy, but only half of the patients can be expected to be panic free after medication. Studies have suggested that individual or group cognitive-behavior therapy (CBT) is an effective treatment strategy for panic patients who have failed to respond to pharmacotherapy. Methods: Thirty-two patients diagnosed with panic disorder with agoraphobia having residual symptoms despite being on an adequate dose of medication were treated with 12 weeks of group CBT. The outcome was evaluated for panic frequency and severity, generalized anxiety, and global severity. Comorbid conditions, a childhood history of anxiety, and defense mechanism styles were assessed as potential predictors of treatment response. Results: Twenty-nine patients completed the 12-week protocol. Treatment was associated with significant reductions in symptom severity on all outcome measures (p < 0.001). Patients with depression had a poorer outcome of the treatment (p = 0.01) as did patients using more neurotic (p = 0.002) and immature defenses (p = 0.05). Conclusion: Consistent with previous reports, we found that CBT was effective for our sample of treatment-resistant patients. Among these patients, depression as well as neurotic defense style was associated with a poorer outcome. The use of CBT in Brazil for treatment-resistant and other panic patients is encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Roy-Byrne, P. P., Stang, P., Wittchen, H.-U., Ustun, B., Walters, E. E., & Kessler, R. C. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.3.229 · Cited by 446
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1485 · Cited by 263
Self-citationLong-term outcome of panic disorder with agoraphobia treated by exposure
FAVA, G. A., RAFANELLI, C., GRANDI, S., CONTI, S., RUINI, C., MANGELLI, L., & BELLUARDO, P. (2001) · Psychological Medicine · doi:10.1017/s0033291701003592 · Cited by 156 · cited 1×
“and treatment of such symptoms may aid relapse prevention [”
BackgroundDoes Cognitive Behavior Therapy Assist Slow-Taper Alprazolam Discontinuation in Panic Disorder?
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.876 · Cited by 153
Overcoming resistance to exposure in panic disorder with agoraphobia
Fava, G. A., Savron, G., Zielezny, M., Grandi, S., Rafanelli, C., & Conti, S. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09636.x · Cited by 59 · cited 1×
“Less information is available for steps to take when patients fail to respond to formal CBT protocols. An initial study of patients who failed to respond to exposure therapy indicated that these patients also tended to demonstrate poor tolerance and compliance to pharmacologic treatment [”
BackgroundCognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series
Whittal, M. L., Otto, M. W., & Hong, J. J. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00067-x · Cited by 44
Self-citation
Cited by
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“, 2002); and addition of group CBT may be beneficial in non-responders to pharmacological approaches [III] (Heldt et al., 2003; Otto et al., 1999; Pollack et al., 1994).”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Stewart, R. E., & Chambless, D. L. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016032 · Cited by 483
King, A. L. S., Valença, A. M., Silva, A. C., Sancassiani, F., Machado, S., & Nardi, A. E. (2014) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901410010028 · Cited by 336
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
“The addition of CBT to medication has been shown to be beneficial in patients with panic disorder that are resistant to medication treatment alone (Heldt et al., 2003; Pollack et al., 1994).”
BackgroundBELZER, K., & SCHNEIER, F. R. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200409000-00003 · Cited by 235
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
Pharmacotherapy of anxiety disorders: A critical review
Koen, N., & Stein, D. J. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/nkoen · Cited by 151
Empirically Supported Treatments for Panic Disorder
McHugh, R. K., Smits, J. A. J., & Otto, M. W. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.05.005 · Cited by 106
Self-citationAligning the many definitions of treatment resistance in anxiety disorders: A systematic review
Bokma, W. A., Wetzer, G. A. A. M., Gehrels, J. B., Penninx, B. W. J. H., Batelaan, N. M., & Balkom, A. L. J. M. (2019) · Depression and Anxiety · doi:10.1002/da.22895 · Cited by 58
“…Mancini, Patterson, & Stein, 2009), 21 open‐label trials (Gabriel & Violato, 2011; Gabriel, 2010; George et al., 2008; Glue et al., 2017, 2018; Heldt et al., 2003; Heldt et al., 2006; Hoge et al., 2008; Hollifield, Thompson, Ruiz, & Uhlenhuth, 2005; Katzman et al., 2008; Kinrys, Vasconcelos…”
Treatment-Resistant Panic Disorder
Bandelow, B., & Rüther, E. (2004) · CNS Spectrums · doi:10.1017/s1092852900022379 · Cited by 57
Otto, M. W., Tolin, D. F., Nations, K. R., Utschig, A. C., Rothbaum, B. O., Hofmann, S. G., & Smits, J. A. J. (2012) · Depression and Anxiety · doi:10.1002/da.21910 · Cited by 54
Self-citationKoh, K. B., & Lee, Y. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000078845 · Cited by 53
Treatment–resistant panic disorder: a systematic review
Freire, R. C., Zugliani, M. M., Garcia, R. F., & Nardi, A. E. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1109628 · Cited by 47
“A decrease in the use of medications was also observed.[31,32] The improvement of panic symptoms persisted for at least a couple of months after the end of the CBT.”
BackgroundSimon, N. M., Otto, M. W., Worthington, J. J., Hoge, E. A., Thompson, E. H., LeBeau, R. T., Moshier, S. J., Zalta, A. K., & Pollack, M. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04485blu · Cited by 45
Self-citationCBT for pharmacotherapy non-remitters—a systematic review of a next-step strategy
Rodrigues, H., Figueira, I., Gonçalves, R., Mendlowicz, M., Macedo, T., & Ventura, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.025 · Cited by 35
“Some studies did not define remission at all and failed to assess it as a potential improvement measure [Hinton et al. (2009), Hinton et al.”
BackgroundInfluentialBiological and cognitive theories explaining panic disorder: A narrative review
Kyriakoulis, P., & Kyrios, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.957515 · Cited by 24
Wesner, A. C., Behenck, A., Finkler, D., Beria, P., Guimarães, L. S. P., Manfro, G. G., Blaya, C., & Heldt, E. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2019.06.003 · Cited by 21
Self-citation
Metadata
- Authors
- Heldt, E., Manfro, G. G., Kipper, L., Blaya, C., Maltz, S., Isolan, L., Hirakata, V. N., & Otto, M. W.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2002-12-16
- Volume
- 72
- Issue
- 1
- Pages
- 43-48
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2089814289
- Cited by
- 87
- References
- 7
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.